首页 | 本学科首页   官方微博 | 高级检索  
     

131例神经系统疾病患者血清中抗BP180和抗BP230抗体的检测
引用本文:王亚如,李洪军,许德志,王建文,周桂芝,杨宝琦. 131例神经系统疾病患者血清中抗BP180和抗BP230抗体的检测[J]. 中国麻风皮肤病杂志, 2018, 34(5): 257
作者姓名:王亚如  李洪军  许德志  王建文  周桂芝  杨宝琦
作者单位:1.济南大学山东省医学科学院医学与生命科学学院,山东 济南,2500622.山东省医学科学院山东省皮肤病性病防治研究所,山东 济南,2500223.泰安市中心医院神经内科,山东 泰安,2710004. 济南市第五人民医院神经外科,山东济南 250022
摘    要:目的:检测神经系统疾病患者血清中抗BP180、抗BP230和抗基底膜带抗体的阳性率。方法:收集神经系统疾病患者和正常对照血清,采用酶联免疫吸附试验(ELISA)和间接免疫荧光(IIF)检测两组血清中抗BPl80NC16A抗体和BP230抗体水平。结果:共收集到131例神经系统疾病患者血清(脑卒中109例,脑肿瘤17例,其他神经系统疾病19例)和131例正常对照血清。病例组中抗BP180NC16A1阳性率为1.45%,低于对照组的3.05%,差异具有统计学差异(P = 0.009),病例组中抗BP230抗体阳性率5.34%与对照组(2.29%)比较,差异无统计学意义。IIF检测抗基底膜带抗体结果均为阴性。结论:抗BP180NC16A抗体在神经系统疾病患者中有较高的阳性率,可能与神经系统疾病患者合并大疱性类天疱疮相关。

关 键 词:大疱性类天疱疮  神经系统疾病  BP180  BP230  基底膜带  

Anti-BP180 and 230 antibodies in 131 patients with neurological diseases
WANG Yaru,LI Hongjun,XU Dezhi,WANG Jianwen,ZHOU Guizhi,YANG Baoqi. Anti-BP180 and 230 antibodies in 131 patients with neurological diseases[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(5): 257
Authors:WANG Yaru  LI Hongjun  XU Dezhi  WANG Jianwen  ZHOU Guizhi  YANG Baoqi
Affiliation:1.School of Medicine and Life Sciences, Jinan University -Shandong Academy of Medical Sciences, Jinan 250062, China; 2.Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Jinan 250022, China; 3.Department of Neurology, Taian City Central Hospital, Taian, 271000,China; 4.Department of Neurosurgery, the 5th People’s Hospital of Jinan, Jinan,250022, China
Abstract:Objective: To detect the level of anti-BP180 and 230 antibodies in the patients with neurological diseases (ND) , but without BP. Methods: The serum and clinical data of the patients with ND and healthy controls were collected. The levels of anti-BP 180, 230 antibodies and anti-basement membrane antibodies were detected by enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence (IIF) respectively. Results: One hundred and thirty-one patients with ND (109 with cerebral apoplexy, 17 with brain tumors and 19 with other neurological disease) and 131 healthy controls were enrolled. Fifteen patients (11.45%) and 4 controls (3.05%) were positive for anti-BP180, NC16A antibodies, with a significant difference of P=0.009. Seven patients (5.34%) and 3 controls (2.29%) were positive for anti-BP 230 antibodies, with no significant difference (P=0.20). The anti-basement membrane antibodies were negative in the patients and healthy controls. Conclusion: The positivity rate of anti-BP180 antibodies was higher in the patients with neurological diseases, which may be associated with the pathogenesis of ND complicated with BP.
Keywords:bullous pemphigoid  neurological disease  BP180  BP230  basement membrane zone  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国麻风皮肤病杂志》浏览原始摘要信息
点击此处可从《中国麻风皮肤病杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号